Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apyx Medical Corporation - Common Stock (NQ:APYX)

2.015 -0.045 (-2.19%)
Streaming Delayed Price Updated: 3:21 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Apyx Medical Corporation (APYX) Investors of Class Action and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Are Apyx Medical Shares Trading Higher Today?
 
Via Benzinga
Apyx Medical: Q1 Earnings Insights
Apyx Medical (NASDAQ:APYX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
APYX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Apyx Medical Corporation
From The Law Offices of Frank R. Cruz
Via Business Wire
APYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors
From Law Offices of Howard G. Smith
Via Business Wire
APYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Apyx Medical Corporation
From Glancy Prongay & Murray LLP
Via Business Wire
Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 575 points on Thursday. 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Apyx Medical Stock Gains Following FDA Clearance of Renuvion Dermal Handpiece for Wrinkle Reduction
The U.S. Food and Drug Administration (FDA) announced 510(k) clearance (pre-market notification) of Apyx Medical’s (NASDAQ: APYX) Renuvion Dermal Handpiece for specific dermal resurfacing procedures. 
Via Benzinga
Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 1.5% on Thursday. 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; US Economy Contracts 1.5% In Q1
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 200 points on Thursday. 
Via Benzinga
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
From Apyx Medical Corporation
Via Business Wire
61 Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June
From Apyx Medical Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Upgrades 
Via Benzinga
NASDAQ:APYX Investor Notice: Investigation over Possible Securities Laws Violations by Apyx Medical Corporation
San Diego, CA -- (SBWIRE) -- 05/13/2022 -- Apyx Medical Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
APYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corp. on Behalf of Apyx Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
From Apyx Medical Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.